Cepham has made a call to action for the natural products industry, urging industry members to rethink how its supports men.
The company believes that the conversation should not just centre around testosterone management and prostate health, but how the industry can support men through every stage of life.
“Men’s health must go beyond the outdated methods of the past," noted Anand Swaroop, Founder and President of Cepham.
Swaroop believes that most modern men have moved past the 'grin and bare it' mindset, and that precision wellness can offer men the chance to optimise their healthspan, rather than just surviving.
By harnessing information from biomarkers and endocrine insights, supplement brands can create products that allow men to thrive throughout all life stages.
To commit to innovation in men's health, Cepham launched Life Phases and Stages (LPAS) Blends, early this year, which provides supplement brands with pre-formulated ingredient systems designed to support critical health milestones for men.
These solutions cover everything from reproductive health and metabolism in early adulthood to sarcopenia, cardiovascular wellness and cognitive preservation in the latter years.
Thanks to advances like continuous glucose monitoring for metabolic resilience, nootropic targeting for early cognitive decline, and therapies integrating entheogen with T+SSRI (testosterone and selective serotonin reuptake inhibitor) models for emotional well-being, men now have more tools to help them take control of their health.
Cepham’s research also addresses emerging concerns such as endocrine disruptors silently impacting male fertility.
“Healthy ageing is no longer about simply adding more years to life—it’s about enhancing quality of life in each stage,” added Swaroop.
“At Cepham, we aim to preserve vitality through muscle, mind, sexual, and emotional health so men can reach their 70s with the energy of their 50s.”
According to Cepham, the LPAS blends offer a modular framework that "aligns with the future of men's health, as consumer demand shifts towards personalisation and function-specific solutions."
